Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Wirth

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Chemotherapy of advanced cancer of the prostateM P Wirth
The Urologic Clinics of North America|May 1, 1993
Immunotherapy for metastatic renal cell carcinomaM P Wirth
Der Urologe. Ausg. A|June 19, 2001
[Gene therapy and immunotherapy in prostatic carcinoma]U Fiedler, M P Wirth
Der Urologe. Ausg. A|April 28, 2016
[Focal therapy is also not chamomile tea : Comment on Apfelbeck et al.: "Focal therapy of prostate cancer in Germany"]M P Wirth, J Huber
Der Urologe. Ausg. A|October 12, 2012
[Age and comorbidity in early prostate cancer]M Fröhner, M P Wirth
Der Urologe. Ausg. A|November 19, 2003
[Chemotherapy of hormone refractory prostate carcinoma]M P Wirth, J Nippgen
Onkologie|July 7, 2001
Etiologic factors in soft tissue sarcomasM Froehner, M P Wirth
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 14, 2007
Lymph node disease after radical prostatectomyM P Wirth, M Froehner
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|June 9, 2006
Co-morbidity in prostate cancerM P Wirth, M Froehner
Der Urologe. Ausg. A|July 1, 1995
[The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma]M P Wirth, C Pilarsky
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Progress in Clinical and Biological Research|January 1, 1990
Chemotherapy of advanced cancer of the prostateM P Wirth
The Urologic Clinics of North America|May 1, 1993
Immunotherapy for metastatic renal cell carcinomaM P Wirth
Der Urologe. Ausg. A|June 19, 2001
[Gene therapy and immunotherapy in prostatic carcinoma]U Fiedler, M P Wirth
Der Urologe. Ausg. A|April 28, 2016
[Focal therapy is also not chamomile tea : Comment on Apfelbeck et al.: "Focal therapy of prostate cancer in Germany"]M P Wirth, J Huber
Der Urologe. Ausg. A|October 12, 2012
[Age and comorbidity in early prostate cancer]M Fröhner, M P Wirth
Der Urologe. Ausg. A|November 19, 2003
[Chemotherapy of hormone refractory prostate carcinoma]M P Wirth, J Nippgen
Onkologie|July 7, 2001
Etiologic factors in soft tissue sarcomasM Froehner, M P Wirth
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|April 14, 2007
Lymph node disease after radical prostatectomyM P Wirth, M Froehner
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|June 9, 2006
Co-morbidity in prostate cancerM P Wirth, M Froehner
Der Urologe. Ausg. A|July 1, 1995
[The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma]M P Wirth, C Pilarsky
Pageof 11